A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Clinical trial NCT05785741 · RECRUITING

Trial details

NCT number: NCT05785741
Sponsor: DualityBio Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-08-17
Primary completion: 2027-12-30
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.